Hydrus Microstent as a Quality of Life Consideration

Status unconfirmed

Conditions studied: Open Angle Glaucoma

In brief

The study aims to identify if Hydrus microstent implantation in patients with open angle glaucoma (OAG) at the time of cataract surgery improves quality of life for patients and explore what quality of life factors motivate patients.

Key facts

Study ID

NCT05955118

Run by

InSight Vision Center Medical Group, Inc

People needed

38

Starts

2023-04-01

Expected to finish

2024-04-01

Last updated by the study team

2023-07-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Clinical diagnosis of mild to moderate open angle glaucoma as defined by with visually significant age-related cataract undergoing uncomplicated cataract surgery and Hydrus Microstent
• Current treatment with one or more ocular hypotensive medication
• Corneal thickness between 470 to 610µm
• Potential of good best corrected visual acuity at distance in the investigator's judgement of at least 0.1 LogMAR (20/25) postoperatively

You may not qualify if…

• Clinical diagnosis of secondary glaucoma (traumatic, neovascular, mixed-mechanism, uveitic glaucoma)
• corneal opacity or angle abnormalities that make visualizing the angle difficult
• Past ocular surgery
• History of ocular, systemic medications, or systemic diseases/co-morbidities that significantly impact on quality of life or vision (e.g. advanced macular degeneration, autoimmune diseases, mental illness/depression, uncontrolled systemic disease on polypharmacy)
• Severe dry eye requiring secretagogues, serum eyedrops, topical corticosteroids, amniotic membrane grafts

Where it is running

• Terri Smith — Fresno, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.